<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Russian Journal of Skin and Venereal Diseases</journal-id><journal-title-group><journal-title xml:lang="en">Russian Journal of Skin and Venereal Diseases</journal-title><trans-title-group xml:lang="ru"><trans-title>Российский журнал кожных и венерических болезней</trans-title></trans-title-group></journal-title-group><issn publication-format="print">1560-9588</issn><issn publication-format="electronic">2412-9097</issn><publisher><publisher-name xml:lang="en">Eco-Vector</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">706392</article-id><article-id pub-id-type="doi">10.17816/dv706392</article-id><article-id pub-id-type="edn">YZYMUQ</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>DERMATOLOGY</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>ДЕРМАТОЛОГИЯ</subject></subj-group><subj-group subj-group-type="article-type"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title xml:lang="en">Association between the skin microbiome composition and disease severity of hidradenitis suppurativa</article-title><trans-title-group xml:lang="ru"><trans-title>Ассоциация состава культивируемой фракции микробиома кожи с клинической тяжестью хронического гнойного гидраденита</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-5800-4800</contrib-id><contrib-id contrib-id-type="spin">8013-3256</contrib-id><name-alternatives><name xml:lang="en"><surname>Teplyuk</surname><given-names>Natalia P.</given-names></name><name xml:lang="ru"><surname>Теплюк</surname><given-names>Наталия Павловна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>MD, Dr. Sci. (Medicine), Professor</p></bio><bio xml:lang="ru"><p>д-р мед. наук, профессор</p></bio><email>teplyukn@gmail.com</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-6372-9910</contrib-id><contrib-id contrib-id-type="spin">6795-0835</contrib-id><name-alternatives><name xml:lang="en"><surname>Vartanova</surname><given-names>Nune O.</given-names></name><name xml:lang="ru"><surname>Вартанова</surname><given-names>Нунэ Оганесовна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Cand. Sci. (Biology)</p>
<p> </p></bio><bio xml:lang="ru"><p>канд. биол. наук</p></bio><email>labmicr@mail.ru</email><xref ref-type="aff" rid="aff2"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0000-5000-8359</contrib-id><contrib-id contrib-id-type="spin">1987-3444</contrib-id><name-alternatives><name xml:lang="en"><surname>Alferova</surname><given-names>Sofia V.</given-names></name><name xml:lang="ru"><surname>Алферова</surname><given-names>Софья Владимировна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><email>sofia.alferova@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-9396-4874</contrib-id><contrib-id contrib-id-type="spin">8014-2724</contrib-id><name-alternatives><name xml:lang="en"><surname>Petukhova</surname><given-names>Eugenia V.</given-names></name><name xml:lang="ru"><surname>Петухова</surname><given-names>Евгения Владимировна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><email>petuxova0304@gmail.com</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-1757-8389</contrib-id><contrib-id contrib-id-type="spin">8802-5569</contrib-id><name-alternatives><name xml:lang="en"><surname>Svitich</surname><given-names>Oxana A.</given-names></name><name xml:lang="ru"><surname>Свитич</surname><given-names>Оксана Анатольевна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>MD, Dr. Sci. (Medicine), Professor, Academician of the Russian Academy of Sciences</p></bio><bio xml:lang="ru"><p>д-р мед. наук, профессор, академик РАН</p></bio><email>svitichoa@yandex.ru</email><xref ref-type="aff" rid="aff1"/><xref ref-type="aff" rid="aff2"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">The First Sechenov Moscow State Medical University (Sechenov University)</institution></aff><aff><institution xml:lang="ru">Первый Московский государственный медицинский университет имени И.М. Сеченова (Сеченовский Университет)</institution></aff></aff-alternatives><aff-alternatives id="aff2"><aff><institution xml:lang="en">I. Mechnikov Research Institute of Vaccines and Sera</institution></aff><aff><institution xml:lang="ru">Научно-исследовательский институт вакцин и сывороток имени И.И. Мечникова</institution></aff></aff-alternatives><pub-date date-type="preprint" iso-8601-date="2026-05-28" publication-format="electronic"><day>28</day><month>05</month><year>2026</year></pub-date><pub-date date-type="pub" iso-8601-date="2026-07-03" publication-format="electronic"><day>03</day><month>07</month><year>2026</year></pub-date><volume>29</volume><issue>3</issue><issue-title xml:lang="en"/><issue-title xml:lang="ru"/><fpage>367</fpage><lpage>374</lpage><history><date date-type="received" iso-8601-date="2026-04-19"><day>19</day><month>04</month><year>2026</year></date><date date-type="accepted" iso-8601-date="2026-05-07"><day>07</day><month>05</month><year>2026</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2026, Eco-Vector</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2026, Эко-Вектор</copyright-statement><copyright-year>2026</copyright-year><copyright-holder xml:lang="en">Eco-Vector</copyright-holder><copyright-holder xml:lang="ru">Эко-Вектор</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/" start_date="2029-07-03"/><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">https://creativecommons.org/licenses/by-nc-nd/4.0/</ali:license_ref></license></permissions><self-uri xlink:href="https://rjsvd.com/1560-9588/article/view/706392">https://rjsvd.com/1560-9588/article/view/706392</self-uri><abstract xml:lang="en"><p><bold>BACKGROUND:</bold> This study presents the results of an investigation into the relationship between the composition of culturable microbiota in skin lesions and disease severity of hidradenitis suppurativa according to the Hurley staging system.</p> <p><bold>AIM:</bold> To assess the relationship between the microbial composition of skin lesions in patients with hidradenitis suppurativa and disease severity according to the Hurley scale.</p> <p><bold>METHODS:</bold> A single-center, retrospective cohort study included 37 patients with hidradenitis suppurativa (median age 38 years), with Hurley stage I in 9 (24.3%), stage II in 12 (32.4%), and stage III in 16 (43.2%). Microorganisms were isolated from lesion exudates and identified using culture-based methods and MALDI-ToF mass spectrometry.</p> <p><bold>RESULTS:</bold> A total of 31 microbial species were identified; the most frequently detected were <italic>Staphylococcus epidermidis </italic>(91.9%), <italic>Staphylococcus haemolyticus</italic> (67.6%), <italic>Corynebacterium amycolatum</italic> (59.5%), and <italic>Staphylococcus aureus</italic> (48.6%). <italic>Staphylococcus hominis</italic> predominated in mild disease (88.9% in stage I vs. 16.7% in stage II and 0% in stage III; <italic>p</italic> &lt; 0.001), whereas <italic>Corynebacterium</italic> species (<italic>C. amycolatum</italic>, <italic>C. aurimucosum</italic>, <italic>C. striatum</italic>, <italic>C. accolens</italic>, <italic>C. tuberculostearicum</italic>, and <italic>C. simulans</italic>) were significantly more common in severe disease (<italic>p</italic> &lt; 0.001). The prevalence of <italic>Enterococcus faecalis</italic> increased significantly with disease progression (0% in stage I, 33.3% in stage II, and 56.3% in stage III; <italic>p</italic>=0.007), along with a trend toward increased prevalence of <italic>S. aureus</italic> (68.8% in stage III vs. 33.3% in stage I; <italic>p</italic>=0.075). A strong positive correlation was found between Hurley stage and the number of microbial species detected (ρ=0.69; <italic>p</italic> &lt; 0.001), indicating increasing microbial diversity as hidradenitis suppurativa progresses.</p> <p><bold>CONCLUSION:</bold> Mild disease was associated with the presence of the commensal S. hominis, whereas severe disease was characterized by <italic>Corynebacterium</italic> predominance and increased microbial diversity. These findings support further investigation of the role of microbiota in the pathogenesis of hidradenitis suppurativa and the development of personalized therapeutic approaches.</p></abstract><trans-abstract xml:lang="ru"><p><bold>Обоснование.</bold> В статье представлены результаты изучения взаимосвязи между составом культивируемой фракции микрофлоры кожных очагов и клинической тяжестью хронического гнойного гидраденита по шкале Hurley.</p> <p><bold>Цель исследования</bold> ― оценка взаимосвязи между микробным составом кожных очагов у пациентов с хроническим гнойным гидраденитом и степенью тяжести заболевания по шкале Hurley.</p> <p><bold>Методы.</bold> В одноцентровом ретроспективном когортном исследовании участвовало 37 пациентов с хроническим гнойным гидраденитом (медиана возраста 38 лет): стадия I по шкале Hurley определена у 9 (24,3%) из них, стадия II ― у 12 (32,4%), стадия III ― у 16 (43,2%). Идентификацию микроорганизмов из отделяемого очагов поражения выполняли культуральными методами и с помощью MALDI-ToF масс-спектрометрии.</p> <p><bold>Результаты.</bold> Выделен 31 вид бактерий, из них наиболее часто встречались <italic>Staphylococcus epidermidis</italic> (91,9%), <italic>Staphylococcus haemolyticus </italic>(67,6%), <italic>Corynebacterium amycolatum</italic> (59,5%) и <italic>Staphylococcus aureus</italic> (48,6%). <italic>Staphylococcus hominis</italic> доминировал при лёгком течении заболевания (88,9% при I стадии против 16,7% при II и 0% при III стадиях; <italic>p</italic> &lt; 0,001), тогда как коринебактерии (<italic>C. amycolatum</italic>,<italic> C. aurimucosum</italic>,<italic> C. striatum</italic>,<italic> C. accolens</italic>,<italic> C. tuberculostearicum</italic>,<italic> C. simulans</italic>) значимо чаще выделялись при тяжёлой стадии (<italic>p</italic> &lt; 0,001). Установлено значимое увеличение частоты <italic>Enterococcus faecalis</italic> при прогрессировании заболевания (0% при I, 33,3% при II и 56,3% при III стадии; <italic>p</italic>=0,007), а также тенденция к повышению частоты <italic>S. aureus</italic> (68,8% при III против 33,3% при I стадии; <italic>p</italic>=0,075). Выявлена прямая корреляция между стадией Hurley и количеством видов микроорганизмов (ρ=0,69; <italic>p</italic> &lt; 0,001), свидетельствующая о нарастании репертуара микроорганизмов при прогрессировании хронического гнойного гидраденита.</p> <p><bold>Заключение.</bold> Лёгкое течение хронического гнойного гидраденита ассоциировано с сохранением комменсала <italic>S. hominis</italic>, тяжёлое ― с преобладанием коринебактерий и увеличением микробного разнообразия, что служит обоснованием для дальнейшего изучения роли микробиоты в патогенезе хронического гнойного гидраденита и разработки персонализированных подходов к терапии.</p></trans-abstract><kwd-group xml:lang="en"><kwd>hidradenitis suppurativa</kwd><kwd>culturable skin microbiome</kwd><kwd>culture-based study</kwd><kwd>Hurley stage</kwd><kwd>polymicrobial colonization</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>гнойный гидраденит</kwd><kwd>культивируемая фракция микробиома кожи</kwd><kwd>культуральное исследование</kwd><kwd>стадия Hurley</kwd><kwd>полимикробность</kwd></kwd-group><funding-group/></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Jemec GB. Clinical practice. Hidradenitis suppurativa. N Engl J Med. 2012;366(2):158–164. doi: 10.1056/NEJMcp1014163</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Zouboulis CC, Desai N, Emtestam L, et al. European S1 guideline for the treatment of hidradenitis suppurativa/acne inversa. J Eur Acad Dermatol Venereol. 2015;29(4):619–644. doi: 10.1111/jdv.12966</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Cucu CI, Giurcăneanu C, Mihai MM, et al. Unraveling the skin microbiome in hidradenitis suppurativa: implications for treatment and disease progression. J Clin Med. 2025;14(7):2424. doi: 10.3390/jcm14072424 EDN: CVZTVG</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Soto-Moreno A, Haselgruber-de Francisco S, León-Pérez J, et al. The microbiome in hidradenitis suppurativa tunnels: a systematic review. Int J Dermatol. 2025;64(10):1802–1812. doi: 10.1111/ijd.17892 EDN: DECUOV</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Ring HC, Thorsen J, Saunte DM, et al. The follicular skin microbiome in patients with hidradenitis suppurativa and healthy controls. JAMA Dermatol. 2017;153(9):897–905. doi: 10.1001/jamadermatol.2017.0904</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Guet-Revillet H, Coignard-Biehler H, Jais JP, et al. Bacterial pathogens associated with hidradenitis suppurativa, France. Emerg Infect Dis. 2014;20(12):1990–1998. doi: 10.3201/eid2012.140064</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Yu C, Yan W, Shucheng H, et al. Roles of skin microbiota in hidradenitis suppurativa: insights from a two-sample mendelian randomization analysis. Arch Dermatol Res. 2025;317(1):346. doi: 10.1007/s00403-024-03702-w EDN: EBNZGB</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Cucu CI, Giurcăneanu C, Poenaru E, et al. Phenotypic and genotypic bacterial virulence and resistance profiles in hidradenitis suppurativa. Int J Mol Sci. 2025;26(8):3502. doi: 10.3390/ijms26083502 EDN: AUGXQI</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>Teplyuk NP, Pirogova AS. Photo gallery. Hidradenitis suppurativa (acne inversa). Russian journal of skin and venereal diseases. 2022;25(4):337–340. doi: 10.17816/dv111836 EDN: ESHCOF</mixed-citation></ref></ref-list></back></article>
